Results 201 to 210 of about 1,745,201 (399)
Abstract The gut microbiota plays a pivotal role in maintaining host metabolic homeostasis and overall physiological functions. Shenling Baizhu San (SLBZS), a time‐honored classical prescription for tonifying Qi, strengthening the spleen, removing dampness, and arresting diarrhea, has shown broad clinical efficacy in digestive disorders.
Jinlan Di, Xiaochun Zhang
wiley +1 more source
The Associations Between Chronic Active Lesions and White Matter Disease: A 7 Tesla Imaging Study
ABSTRACT Background The relationship between paramagnetic rim lesions (PRLs) and surrounding normally appearing white matter (NAWM) disease, potentially contributory to the associations seen between PRLs and clinical impairment, is underexplored. Objectives To assess whether PRLs correlate with a greater degree of NAWM injury in early MS.
Ellie McCluey +17 more
wiley +1 more source
Sebum's effect on wound healing and pigmentation in mice. [PDF]
Lee KJ, An HY, Choi GS, Shin HT, Shin J.
europepmc +1 more source
THE EFFECT OF' ACTH AND CORTISONE ON WOUND HEALING
E. MEREDITH ALRICIT +2 more
openalex +2 more sources
WOUND HEALING AND COLLAGEN FORMATION [PDF]
Russell Ross, Earl P. Benditt
openalex +1 more source
Long‐Term Temporal Profile of Motor Recovery After Intracerebral Hemorrhage
ABSTRACT Objective Limited data is available to describe the temporal profile of long‐term recovery over 1 year after the stroke in patients with spontaneous intracerebral hemorrhage (ICH). Methods A registered multicentral cohort was conducted to consecutively include non‐herniated supratentorial ICH patients from November 2013 to January 2023 ...
Yan Zheng +24 more
wiley +1 more source
DIFFERENCES BETWEEN THE RATE OF HEALING OF WOUNDS INFLICTED WITH SHORT TIME INTERVAL
Ph. Sandblom, A. MUREN
openalex +2 more sources
WOUND HEALING AND COLLAGEN FORMATION [PDF]
Russell Ross, Earl P. Benditt
openalex +1 more source
Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis
ABSTRACT Objectives Ocrelizumab (OCR), a humanized anti‐CD20 monoclonal antibody, is highly efficient in relapsing–remitting multiple sclerosis (RR‐MS). We assessed early cellular B‐cell profiles in patients prior to OCR treatment, on OCR treatment, and after 15 months of therapy discontinuation.
Alexandra Garcia +20 more
wiley +1 more source

